Advertisement
Organisation › Details
Polyplus-transfection S.A.
Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bioproduction and therapeutics. Located close to the University of Strasbourg in Eastern France, Polyplus-transfection has been ISO 9001-certified since 2002 and supplies its proprietary range of reagents for the transfection of genes, oligonucleotides and siRNA through a worldwide distributor network. Polyplus reagents are involved in a growing number of clinical trials worldwide. In addition, Polyplus-transfection holds a broad estate of patents and licenses including original methods for therapeutic siRNA delivery. *
Start | 2001-01-01 splitoff | |
Group | Sartorius (Group) | |
Predecessor | University of Strasbourg | |
Industry | transfection reagents | |
Person | Philips, Mario (Polyplus-transfection, 202011– CEO before PolyNeuros + ArchiMed + Pall Biotech + ATMI Life Sciences) | |
Person 2 | Festoc, Gabriel (Polyplus-transfection 201609 CEO before CEO + Founder of GeneSystems) | |
Region | Illkirch | |
Country | France | |
Street | Boulevard Sébastien Brant Bioparc | |
City | 67400 Illkirch | |
Tel | +33-3-9040-6180 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | D: 101 to 500 (2023-03-31) |
* Document for »About Section«: | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Sartorius (Group)
- [1] Sartorius AG. (8/17/23). "Press Release: Sartorius and Repligen Corporation Launch Integrated System with Biostat STR and XCell ATF for Upstream Process Intensification". Göttingen....
- [2] Sartorius AG. (8/3/23). "Press Release: Florian Funck Appointed CFO of Sartorius. New CFO to Take Over as of April 2024". Göttingen....
- [3] Waters Corporation. (6/5/23). "Press Release: Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing". Milford, MA & Göttingen....
- [4] Sartorius. (3/31/23). "Press Release: Sartorius to Acquire Polyplus. France-based Polyplus Is a Provider of Innovative Upstream Technologies for Cell and Gene Therapies". Göttingen....
- [5] Sartorius AG. (7/21/22). "Press Release: Sartorius Remains on Growth Track. Figures for the First Half of 2022 – Sales Revenue up 20.9 Percent in Constant Currencies, Underlying EBITDA up 25.6 Percent, Underlying EBITDA Margin 33.9 Percent". Göttingen...
- [6] Sartorius Stedim Biotech S.A.. (7/21/22). "Press Release: Half-year Results 2022 of Sartorius Stedim Biotech. Sales Revenue up 22.1 Percent in Constant Currencies, Underlying EBITDA Margin 35.2 Percent ". Aubagne....
- [7] Polyplus-transfection S.A.. (3/9/22). "Press Release: Polyplus-transfection Acquires Biowire to further Expand into Asia-Pacific Gene and Cell Therapy Markets". Strasbourg....
- [8] Waters Corporation. (10/27/21). "Press Release: Waters and Sartorius Partner to Help Bioprocess Scientists Accelerate Clone Selection and Process Development". Milford, MA & Göttingen....
- [9] Sartorius AG. (9/27/21). "Press Release: Sartorius to Expand Business Operations in North America". Ann Arbor, MI....
- [10] Sartorius AG. (7/2/21). "Press Release: Sartorius Strengthens Product Portfolio for Cell and Gene Therapies by Acquiring a Majority Stake in CellGenix". Göttingen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top